Karen Chung

2.9k total citations · 1 hit paper
106 papers, 2.0k citations indexed

About

Karen Chung is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Karen Chung has authored 106 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Oncology, 28 papers in Surgery and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Karen Chung's work include Bone health and treatments (32 papers), Management of metastatic bone disease (22 papers) and Cancer Diagnosis and Treatment (22 papers). Karen Chung is often cited by papers focused on Bone health and treatments (32 papers), Management of metastatic bone disease (22 papers) and Cancer Diagnosis and Treatment (22 papers). Karen Chung collaborates with scholars based in United States, United Kingdom and Switzerland. Karen Chung's co-authors include Yi Qian, Thomas E. Delea, May Hagiwara, Roger Dansey, Ada Braun, Donald L. Patrick, Lesley Fallowfield, Matthew Gitlin, Qi Jiang and Lincoln Nadauld and has published in prestigious journals such as The Lancet, Circulation and Journal of Clinical Oncology.

In The Last Decade

Karen Chung

95 papers receiving 1.9k citations

Hit Papers

Blood-based tests for multicancer early detection (PATHFI... 2023 2026 2024 2025 2023 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study
    2023 168 citations Deborah Schrag, Charles H. McDonnell et al. profile →

Peers

Karen Chung
Hugues Bourgeois France
Marianne Schmid Germany
Oscar Bertetto Italy
Mario Di Palma France
C S Thomson United Kingdom
Hui Zhao United States
Rohini K. Hernandez United States
James Khatcheressian United States
Robert Cooper United Kingdom
Maureen P. Neary United States
Hugues Bourgeois France
Karen Chung
Citations per year, relative to Karen Chung Karen Chung (= 1×) peers Hugues Bourgeois

Countries citing papers authored by Karen Chung

Since Specialization
Citations

This map shows the geographic impact of Karen Chung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Chung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Chung more than expected).

Fields of papers citing papers by Karen Chung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Chung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Chung. The network helps show where Karen Chung may publish in the future.

Co-authorship network of co-authors of Karen Chung

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Chung. A scholar is included among the top collaborators of Karen Chung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Chung. Karen Chung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marinac, Catherine R., Charles H. McDonnell, Lincoln Nadauld, et al.. (2025). Clinical Evaluation of Cancer Signal Origin Prediction and Diagnostic Resolution following Multicancer Early Detection Testing in the PATHFINDER Study. Cancer Prevention Research. 18(8). 475–483.
2.
Matza, Louis S., Eric T. Fung, Sam M. Janes, et al.. (2024). Health State Utilities Associated with False-Positive Cancer Screening Results. PharmacoEconomics - Open. 8(2). 263–276. 2 indexed citations
3.
Chung, Karen, et al.. (2024). Diagnostic test use and time to cancer diagnosis in Medicare recipients.. Journal of Clinical Oncology. 42(16_suppl). 1622–1622.
4.
Chung, Karen, et al.. (2024). Symptom impact and health-related quality of life (HRQoL) assessment by cancer stage: a narrative literature review. BMC Cancer. 24(1). 884–884. 13 indexed citations
5.
Chung, Karen, et al.. (2023). Out-of-pocket cost by cancer stage at diagnosis in commercially insured patients in the United States. Journal of Medical Economics. 26(1). 1318–1329. 5 indexed citations
6.
Pinson, Marisa R., Alexander M. Tseng, Karen Chung, et al.. (2023). Maternal circulating miRNAs contribute to negative pregnancy outcomes by altering placental transcriptome and fetal vascular dynamics. PLoS ONE. 18(11). e0290720–e0290720. 2 indexed citations
7.
Klein, Eric A., Charles H. McDonnell, Lincoln Nadauld, et al.. (2023). Clinical evaluation of cancer signal origin prediction and diagnostic resolution following multi-cancer early detection testing.. Journal of Clinical Oncology. 41(16_suppl). 10520–10520. 1 indexed citations
8.
Pinson, Marisa R., Alexander M. Tseng, Karen Chung, et al.. (2022). Prenatal alcohol exposure contributes to negative pregnancy outcomes by altering fetal vascular dynamics and the placental transcriptome. Alcoholism Clinical and Experimental Research. 46(6). 1036–1049. 12 indexed citations
9.
Gelhorn, Heather L., Melissa Ross, M. Feldman, et al.. (2022). Patient Preferences for Multi-Cancer Early Detection (MCED) Screening Tests. Patient. 16(1). 43–56. 23 indexed citations
10.
Chung, Karen, et al.. (2022). Increased healthcare costs by later stage cancer diagnosis. BMC Health Services Research. 22(1). 1155–1155. 50 indexed citations
11.
Hackshaw, Allan, Sarah S. Cohen, Heidi Reichert, et al.. (2021). Estimating the population health impact of a multi-cancer early detection genomic blood test to complement existing screening in the US and UK. British Journal of Cancer. 125(10). 1432–1442. 55 indexed citations
12.
Cohen, Sarah S., Heidi Reichert, M. Feldman, et al.. (2020). PCN272 IMPROVED EFFICIENCY OF CANCER SCREENING WITH A MULTI-CANCER EARLY DETECTION TEST. Value in Health. 23. S71–S71. 1 indexed citations
13.
Roberts, D. Allen, Roxanne P. Kerani, Emily Scott, et al.. (2019). Harambee!: A pilot mixed methods study of integrated residential HIV testing among African-born individuals in the Seattle area. PLoS ONE. 14(5). e0216502–e0216502. 12 indexed citations
14.
Jensen, I., et al.. (2018). Budget Impact Analysis of Using Daunorubicin-Cytarabine Liposome in Patients with Newly Diagnosed Therapy-Related AML or AML and Myelodysplasia-Related Changes.. Europe PMC (PubMed Central). 11(7). 380–386. 7 indexed citations
15.
16.
Hagiwara, May, Thomas E. Delea, & Karen Chung. (2014). Healthcare costs associated with skeletal-related events in breast cancer patients with bone metastases. Journal of Medical Economics. 17(3). 223–230. 25 indexed citations
17.
Hagiwara, May, Thomas E. Delea, Ze Cong, & Karen Chung. (2013). Utilization of intravenous bisphosphonates in patients with bone metastases secondary to breast, lung, or prostate cancer. Supportive Care in Cancer. 22(1). 103–113. 20 indexed citations
18.
19.
Pockett, Rhys, Daniel Castellano, Phil McEwan, et al.. (2009). The hospital burden of disease associated with bone metastases and skeletal-related events in patients with breast cancer, lung cancer, or prostate cancer in Spain. European Journal of Cancer Care. 19(6). 755–760. 97 indexed citations
20.
Berger, Ariel, Karen Chung, David Gelmont, & Gerry Oster. (2004). Clinical Outcomes in Patients With Alpha1-Antitrypsin Deficiency And Emphysema Receiving Alpha1-Proteinase Inhibitor Augmentation Therapy. CHEST Journal. 126(4). 708S–708S. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hugues Bourgeois Breakdown of academic impact, for papers by Marianne Schmid Breakdown of academic impact, for papers by Oscar Bertetto Breakdown of academic impact, for papers by Mario Di Palma Breakdown of academic impact, for papers by C S Thomson Breakdown of academic impact, for papers by Hui Zhao Breakdown of academic impact, for papers by Rohini K. Hernandez Breakdown of academic impact, for papers by James Khatcheressian Breakdown of academic impact, for papers by Robert Cooper Breakdown of academic impact, for papers by Maureen P. Neary
Rankless by CCL
2026